Estrella Immunopharma, Inc. (ESLA)
Data as of , from SEC Form 4 filings.
See up to 3 months of ESLA. The 7-day demo opens the 1M and 3M ranges and puts ESLA on your watchlist.
Start 7-day demoLatest ESLA insider trades
Jiandong Xu - OfficerOpen-market purchase$104- Jiandong Xu - OfficerOpen-market purchase
About Estrella Immunopharma, Inc. (ESLA)
Estrella Immunopharma, Inc. is an SEC registrant, filing under CIK 0001844417, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector. It filed a registration statement with the SEC on 22 December 2025 and has not yet priced an offering.
ESLA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Option exercise | 4 | 400,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ESLA insider transactions (Form 4)
73 Form 4 filings on record, the earliest from Apr 30, 2026, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Cheng Liu - Officer | Option exercise | Common Stock, par value $0.0001 per share | 100,000 | $0.82 footnote F1 | $82K | |
| Cheng Liu - Officer | Option exercise | Incentive Stock Option | 100,000 | $0.00 footnote F4 | - | |
| ||||||
| Jiandong Xu - Officer | Option exercise | Common Stock, par value $0.0001 per share | 100,000 | $0.82 footnote F1 | $82K | |
| Jiandong Xu - Officer | Option exercise | Incentive Share Option | 100,000 | - footnote F4 | - | |
| ||||||
| Jiandong Xu - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 100 | $1.04 | $104 | |
| Jiandong Xu - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 1,000 | $1.33 | $1K | |
| Jiandong Xu - Officer | Open-market purchase | Common Stock, par value $0.0001 per share | 1,000 | $1.16 | $1K | |
ESLA insider trading FAQ
What is the latest insider trade for ESLA?
Estrella Immunopharma, Inc. (ESLA) had 2 insider filings in the last 90 days, with the most recent on 26 August 2026. The full record for ESLA runs to 3 Form 4 filings, the earliest from 30 April 2026. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ESLA stock?
No insider purchases of ESLA were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling ESLA stock?
No insider sales of ESLA were filed in the last 90 days.
Where can I see ESLA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ESLA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
3The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Cheng Liu view on EDGAR
- - Jiandong Xu view on EDGAR
- - Jiandong Xu view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ESLA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ESLA with a 7-day demo
- ESLA on your watchlist
- Every ESLA Form 4 filing on record
- Up to 3 months of ESLA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
